Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lilotomab (HH1) is a murine anti-CD37 antibody with anti-tumor activity. It can be used as a synthetic anti-CD37 antibody-radionuclide coupling (177Lu-lilotomab satetraxetan).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $263 | In Stock | |
5 mg | $723 | In Stock | |
10 mg | $986 | In Stock | |
25 mg | $1,490 | In Stock | |
50 mg | $1,970 | In Stock |
Description | Lilotomab (HH1) is a murine anti-CD37 antibody with anti-tumor activity. It can be used as a synthetic anti-CD37 antibody-radionuclide coupling (177Lu-lilotomab satetraxetan). |
In vitro | Lilotomab (0-40 µg/mL, treated for 12 days) significantly reduced clone formation survival of DOHH2 and Ramos cells. Lilotomab (40 µg/mL, 18 hours of treatment) produced mild apoptotic effects on DOHH2 cells. [1] |
In vivo | In a mouse model, Lilotomab (0.5 mg/kg, i.v., single dose) effectively inhibited tumor growth. [1] |
Alias | HH1 |
Cas No. | 1453362-55-4 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.